Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endocyte ECYT

Healthcare Biotechnology
"Endocyte Inc is a biopharmaceutical company. It is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases."

Recent & Breaking News (NDAQ:ECYT)

Endocyte to Present at the Jefferies 2013 Global Healthcare Conference

Globe Newswire May 29, 2013

Endocyte Appoints Scot L. Harper, Ph.D., as Vice President of Clinical Operations

Globe Newswire May 7, 2013

Endocyte Reports First Quarter 2013 Financial Results and Business Update

Globe Newswire May 2, 2013

Clinical Study Shows Involvement of Activated Macrophages in Osteoarthritis, Identified by Endocyte's Etarfolatide

Globe Newswire April 25, 2013

Endocyte, Inc. Announces Annual Stockholders' Meeting

Globe Newswire April 22, 2013

Endocyte Announces First Quarter 2013 Earnings Conference Call

Globe Newswire April 18, 2013

Endocyte Announces Presentations at AACR Annual Meeting 2013

Globe Newswire April 3, 2013

Endocyte to Present at the Future Leaders in the Biotech Industry Conference

Globe Newswire April 1, 2013

InvestorsGuru.com 35 Filtered Mid-Day Market Movers Recap

Investors Guru March 31, 2013

Free Research Reports on CHTP, ECYT, MFRM and RVLT Issued by the Bedford Report

Marketwired March 28, 2013

Endocyte to Webcast Investor and Analyst Day in New York City

Troy Schwensen March 18, 2013

Endocyte's Investigational Diagnostic Imaging Agent Etarfolatide Identifies Ovarian Cancer and Non-Small Cell Lung Cancer Patients Most Likely to Benefit From Folate Receptor-Targeted Treatment, New Analysis Shows

Troy Schwensen March 1, 2013

Endocyte to Present at Upcoming Conferences in March

Troy Schwensen February 26, 2013

Endocyte Reports Fourth Quarter and Year End 2012 Financial Results and Business Update

Troy Schwensen February 25, 2013

Endocyte to Present at Upcoming Conferences

Troy Schwensen February 7, 2013

Endocyte Announces Fourth Quarter and Full Year 2012 Earnings Conference Call

Troy Schwensen February 6, 2013

Endocyte to Advance Development of EC1069, a PSMA-Targeted Small Molecule Drug Conjugate Therapy for Prostate Cancer

Troy Schwensen January 29, 2013

Dr. Lesley Russell Joins the Endocyte Board of Directors

Troy Schwensen January 8, 2013